Cipla receives EIR for its Indore facility

Capital Market

Last Updated : Oct 14 2016 | 12:02 AM IST

From USFDA

Cipla has received Establishment Inspection Report (EIR) from the US FDA for its Indore facility indicating formal closure of the US FDA inspection conducted in July/August, 2015.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

K E C International secures new orders

Nitesh Estates announces resignation of director

Ashapura Intimates Fashion wins Entrepreneur Excellence Award 2016

Wall Street Finance announces change in directorate

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 13 2016 | 12:10 PM IST

Explore News

Stock Market LIVE Stocks to Watch Today Nifty Outlook Stocks to buy today Venezuela's Stock Market Gold and Silver Rate Today Stray Dogs Case ICC Rejects Bangladesh Request US Move on Venezuela Oil Personal Finance